Anti-PTC1/ PTCH1/ BCNS monoclonal antibody

Anti-PTC1/ PTCH1/ BCNS antibody for FACS & in-vivo assay

Target products collectionGo to PTCH1/PTCH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1421-Ab-1/ GM-Tg-hg-MP1421-Ab-2Anti-Human PTCH1 monoclonal antibodyHuman
GM-Tg-rg-MP1421-Ab-1/ GM-Tg-rg-MP1421-Ab-2Anti-Rat PTCH1 monoclonal antibodyRat
GM-Tg-mg-MP1421-Ab-1/ GM-Tg-mg-MP1421-Ab-2Anti-Mouse PTCH1 monoclonal antibodyMouse
GM-Tg-cynog-MP1421-Ab-1/ GM-Tg-cynog-MP1421-Ab-2Anti-Cynomolgus/ Rhesus macaque PTCH1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1421-Ab-1/ GM-Tg-felg-MP1421-Ab-2Anti-Feline PTCH1 monoclonal antibodyFeline
GM-Tg-cang-MP1421-Ab-1/ GM-Tg-cang-MP1421-Ab-2Anti-Canine PTCH1 monoclonal antibodyCanine
GM-Tg-bovg-MP1421-Ab-1/ GM-Tg-bovg-MP1421-Ab-2Anti-Bovine PTCH1 monoclonal antibodyBovine
GM-Tg-equg-MP1421-Ab-1/ GM-Tg-equg-MP1421-Ab-2Anti-Equine PTCH1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1421-Ab-1/ GM-Tg-hg-MP1421-Ab-2; GM-Tg-rg-MP1421-Ab-1/ GM-Tg-rg-MP1421-Ab-2;
GM-Tg-mg-MP1421-Ab-1/ GM-Tg-mg-MP1421-Ab-2; GM-Tg-cynog-MP1421-Ab-1/ GM-Tg-cynog-MP1421-Ab-2;
GM-Tg-felg-MP1421-Ab-1/ GM-Tg-felg-MP1421-Ab-2; GM-Tg-cang-MP1421-Ab-1/ GM-Tg-cang-MP1421-Ab-2;
GM-Tg-bovg-MP1421-Ab-1/ GM-Tg-bovg-MP1421-Ab-2; GM-Tg-equg-MP1421-Ab-1/ GM-Tg-equg-MP1421-Ab-2
Products NameAnti-PTCH1 monoclonal antibody
Formatmab
Target NamePTCH1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PTCH1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PTC1/ PTCH1/ BCNS VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1421
    Target NamePTCH1
    Gene ID5727,19206,89830,718751,484137,101085077,520994,100033936
    Gene Symbol and SynonymsA230106A15Rik,BCNS,BCNS1,mes,NBCCS,PTC,PTC1,PTCH,PTCH1,Ptch2,wig
    Uniprot AccessionQ13635
    Uniprot Entry NamePTC1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000185920
    Target ClassificationTumor-associated antigen (TAA)

    The target: PTCH1, gene name: PTCH1, also named as BCNS, NBCCS, PTC, PTC1, PTCH. This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.